Neuralink secures $650M series E funding to expand patient access to brain chip technology
The company has hit significant milestones in the past year. Neuralink says its conducted more human clinical trials, implanting its brain chips in five patients with severe paralysis.
The company has hit significant milestones in the past year. Neuralink says its conducted more human clinical trials, implanting its brain chips in five patients with severe paralysis.
